Larimar Therapeutics Inc. (LRMR)
2.64
-0.39 (-12.87%)
At close: Mar 03, 2025, 3:59 PM
2.60
-1.52%
After-hours: Mar 03, 2025, 06:37 PM EST
Larimar Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -36.95M | -35.35M | -50.64M | -42.48M | -23.13M | -61.37M | -52.03M | -57.88M | -74.29M | -36.48M | -14.03M | -13.88M | -13.16M |
| Depreciation & Amortization | 311K | 318K | 326K | 155K | 78K | 261K | 188K | 212K | 70K | 16K | 12K | 11K | 4K |
| Stock-Based Compensation | 7.62M | 6.62M | 5.47M | 2.16M | 129K | 173K | n/a | n/a | 8.58M | 1.55M | n/a | n/a | n/a |
| Other Working Capital | -2.11M | 1.64M | 3.72M | 1.25M | -2.4M | 827K | 454K | -6.47M | 7.74M | -815K | -397K | 692K | 801K |
| Other Non-Cash Items | -1.93M | -820K | -15K | 10K | -3.63M | 9.78M | 9.08M | 10.64M | 9.09M | 6.67M | 645K | 218K | 78K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 3.63M | -9.63M | n/a | n/a | -8.58M | -815K | n/a | n/a | n/a |
| Change in Working Capital | -2.51M | 1.67M | 2.75M | -2.04M | 226K | 593K | -99K | -5.5M | 6.73M | 815K | -1.63M | 62K | 801K |
| Operating Cash Flow | -33.46M | -27.57M | -42.1M | -42.2M | -22.7M | -51.49M | -43.78M | -51.98M | -59.55M | -28.24M | -15M | -13.59M | -12.27M |
| Capital Expenditures | -164K | -100K | -333K | -62K | -83K | -108K | -55K | -660K | -595K | -58K | -17K | -2K | -35K |
| Acquisitions | -33.52K | 90.86K | -24.5K | -1.3M | -26.03M | 6.76M | n/a | n/a | 91.5M | n/a | n/a | n/a | 2K |
| Purchase of Investments | -101.23M | -133.61M | -8.25M | -24.49M | -82.86M | -117.15M | -114.51M | -136.53M | -287.49M | -57.2M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 134.75M | 42.75M | 32.75M | 1M | 109.47M | 110.39M | 150.21M | 188.6M | 195.99M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 33.52K | -90.86K | 24.5K | 41.93M | -583K | -6.76M | 35.7M | 35K | -19K | -57K | n/a | n/a | -12K |
| Investing Cash Flow | 33.35M | -90.96M | 24.17M | 17.09M | -83K | -6.87M | 35.65M | 51.45M | -92.12M | -57.31M | -17K | -2K | -45K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | 16.37M | -2.94M | -1.38M | 7.34M | n/a | 5.99M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | 67.22M | 195K | 220K | 131.02M | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 30K | n/a | n/a | 18M | 19.39M | n/a | n/a | n/a | n/a | n/a | n/a | 13K | n/a |
| Financial Cash Flow | 30K | 75.26M | 19.89M | 93.59M | 19.39M | 66.91M | 16.56M | -2.71M | 129.16M | 108.14M | 40.6M | 22.06M | 10.07M |
| Net Cash Flow | -76K | -43.27M | 1.95M | 68.48M | -3.39M | 8.55M | 8.43M | -3.24M | -22.51M | 22.59M | n/a | n/a | n/a |
| Free Cash Flow | -33.62M | -27.67M | -42.44M | -42.26M | -22.78M | -51.59M | -43.84M | -52.63M | -60.15M | -28.3M | -15.02M | -13.59M | -12.31M |